The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: A hospital cohort study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Brown, Kevin A ^a   Fisman, David N ^a   Moineddin, Rahim ^b   Daneman, Nick ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LAXATIVE; LINCOSAMIDE; MACROLIDE; NITROFURANTOIN; PENICILLIN DERIVATIVE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; RISK ASSESSMENT; TERTIARY CARE CENTER; TREATMENT DURATION; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84929263777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105454     Document Type: Article

References (38)

1. Kuntz J, Chrischilles E, Pendergast J, Herwaldt L, Polgreen P (2011) Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study. BMC Infect Dis 11: 194.
2. Kelly CP, LaMont JT (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359: 1932-1940. doi:10.1056/NEJMra0707500.
3. Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M (2012) Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada. Antimicrob Agents Chemother 56: 639-646. doi:10.1128/AAC.05411-11.
4. Polgreen PM, Yang M, Bohnett LC, Cavanaugh JE (2010) A time-series analysis of Clostridium difficile and its seasonal association with influenza. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am 31: 382-387. doi:10.1086/651095.
5. Brown KA, Daneman N, Arora P, Moineddin R, Fisman DN (2013) The co-seasonality of pneumonia and influenza with Clostridium difficile infection in the United States, 1993-2008. Am J Epidemiol 178: 118-125. doi:10.1093/aje/kws463.
6. Britton RA, Young VB (2012) Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol 20: 313-319. doi:10.1016/j.tim.2012.04.001.
7. Tancrède C (1992) Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 11: 1012-1015.
8. Delaney JAC, Dial S, Barkun A, Suissa S (2007) Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis 13: 761-763. doi:10.3201/eid1305.061124. (Pubitemid 46698741)
9. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S (2008) Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. Can Med Assoc J 179: 767-772. doi:10.1503/cmaj.071812.
10. Chang HT, Krezolek D, Johnson S, Parada JP, Evans CT, et al. (2007) Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am 28: 926-931. doi:10.1086/519178. (Pubitemid 47218271)
11. Dubberke ER, McMullen KM, Mayfield JL, Reske KA, Georgantopoulos P, et al. (2009) Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am 30: 332-337. doi:10.1086/596604.
12. Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA (2005) Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am 26: 680-684. doi:10.1086/502602. (Pubitemid 41169736)
13. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis Off Publ Infect Dis Soc Am 53: 42-48. doi:10.1093/cid/cir301.
14. Stevens V, van Wijngaarden E (2011) Ignoring the variability in timing of drug administrations attenuates hazard ratios. Am J Epidemiol 173: S272.
15. Abrahamowicz M, Beauchamp M-E, Sylvestre M-P (2012) Comparison of alternative models for linking drug exposure with adverse effects. Stat Med 31: 1014-1030. doi:10.1002/sim.4343.
16. Provincial Infectious Diseases Advisory Committee (2007) Best practices document for the management of Clostridium difficile in all health care settings protecting patients and staff. Toronto.
17. WHO Collaborating Centre for Drug Statistics Methodology, Folkehelseinstituttet (Noruega) (2013) Guidelines for ATC classification and DDD assignment 2014. Oslo: WHO Collaborating Centre for Drug Statistics Methodology: Norwegian Institute of Public Health. Available: http://www.whocc.no/filearchive/publications/2014guidelines.pdf. Accessed 5 June 2014.
18. Brown KA, Khanafer N, Daneman N, Fisman DN (2013) Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection. Antimicrob Agents Chemother 57: 2326-2332. doi:10.1128/AAC.02176-12.
19. Dubberke ER, Reske KA, Olsen MA, McMullen KM, Mayfield JL, et al. (2007) Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med 167: 1092-1097. doi:10.1001/archinte.167.10.1092. (Pubitemid 46835798)
20. Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, et al. (1998) Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 129: 1012-1019. (Pubitemid 29005824)
21. Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case-cohort designs. J Clin Epidemiol 52: 1165-1172. (Pubitemid 29535416)
22. Peduzzi P, Concato J, Feinstein AR, Holford TR (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48: 1503-1510. (Pubitemid 26035533)
23. Bignardi GE (1998) Risk factors for Clostridium difficile infection. J Hosp Infect 40: 1-15. doi:10.1016/S0195-6701(98)90019-6.
24. Hanley JA, Negassa A, Edwardes MD deB, Forrester JE (2003) Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157: 364-375. (Pubitemid 36196757)
25. Pan W (2001) Akaike's information criterion in generalized estimating equations. Biometrics 57: 120-125.
26. Højsgaard S, Halekoh U, Yan J (2006) The R Package geepack for Generalized Estimating Equations. J Stat Softw 15/2: 1-11. (Pubitemid 43037444)
27. Jump RLP, Li Y, Pultz MJ, Kypriotakis G, Donskey CJ (2011) Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production. Antimicrob Agents Chemother 55: 546-549. doi:10.1128/AAC.00839-10.
28. Baines SD, Crowther GS, Todhunter SL, Freeman J, Chilton CH, et al. (2013) Mixed infection by Clostridium difficile in an in vitro model of the human gut. J Antimicrob Chemother 68: 1139-1143. doi:10.1093/jac/dks529.
29. Hensgens MPM, Goorhuis A, Dekkers OM, Kuijper EJ (2012) Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 67: 742-748. doi:10.1093/jac/dkr508.
30. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am 31: 431-455. doi:10.1086/651706.
31. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ: 5-338.
32. Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci Publ: 1-406.
33. Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M (2013) Hospital-acquired infections - appropriate statistical treatment is urgently needed! Int J Epidemiol. doi:10.1093/ije/dyt111.
34. Halloran ME, Struchiner CJ (1991) Study designs for dependent happenings. Epidemiology 2: 331-338.
35. Ajao AO, Harris AD, Roghmann M-C, Johnson JK, Zhan M, et al. (2011) Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition. Infect Control Hosp Epidemiol 32: 481-489. doi:10.1086/659403.
36. Cherrie JW, Semple S, Christopher Y, Saleem A, Hughson GW, et al. (2006) How Important is Inadvertent Ingestion of Hazardous Substances at Work? Ann Occup Hyg 50: 693-704. doi:10.1093/annhyg/mel035. (Pubitemid 44535993)
37. Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 69: 881-891. doi:10.1093/jac/dkt477.
38. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, et al. (2013) Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369: 1195-1205. doi:10.1056/NEJMoa1216064.